@fluxed@ieji.deA new study finds that popular weight loss drug #Ozempic "could be profitably produced for less than $5 a month, even as maker Novo Nordisk A/S charges almost $1,000 in the US..."
The company's combined 2023 sales of Ozempic and related product Wegovy topped $18 billion.
#bigpharma
@PaulWermer@sfba.socialoh my, is it possible that #BigPharma has been less than honest about their development costs?
https://www.
@paulwermer@sfba.socialoh my, is it possible that #BigPharma has been less than honest about their development costs?
https://www.
@fluxed@ieji.deA new study finds that popular weight loss drug #Ozempic "could be profitably produced for less than $5 a month, even as maker Novo Nordisk A/S charges almost $1,000 in the US..."
The company's combined 2023 sales of Ozempic and related product Wegovy topped $18 billion.
#bigpharma
@unchartedworlds@scicomm.xyzgood rant about bad weight-loss rhetoric
From Kate Manne.
"... the measure so-called obesity is based on, the BMI, is hopelessly flawed and simplistic. The likely reason that the AMA ignored these worries and deemed obesity a disease anyway can be gleaned by following the money: the new weight loss drugs Belviq and Qsymia had been introduced to the market just prior, and were not selling as well as predicted."
#BMI #BadScience #drugs #BigPharma #Oprah